Immun Ageing. 2010 Sep 7;7:13.

Immunosenescence and Cytomegalovirus: where do we stand after a decade?

Department of Internal Medicine II, University of Tübingen, Tübingen, Germany. graham.pawelec@uni-tuebingen.de.

Supplemental Content

Review Human immunosenescence: is it infectious? [Immunol Rev. 2005]
Review Human immunosenescence: is it infectious?
Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A. Immunol Rev. 2005 Jun; 205:257-68.
Review Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. [Curr Opin Immunol. 2009]
Review Biomarkers of human immunosenescence: impact of Cytomegalovirus infection.
Derhovanessian E, Larbi A, Pawelec G. Curr Opin Immunol. 2009 Aug; 21(4):440-5. Epub 2009 Jun 15.
Review Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? [Blood. 1994]
Review Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand?
Forman SJ, Zaia JA. Blood. 1994 May 1; 83(9):2392-8.
Review Is immunosenescence infectious? [Trends Immunol. 2004]
Review Is immunosenescence infectious?
Pawelec G, Akbar A, Caruso C, Effros R, Grubeck-Loebenstein B, Wikby A. Trends Immunol. 2004 Aug; 25(8):406-10.
Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. [Am J Obstet Gynecol. 2009]
Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis.
Cahill AG, Odibo AO, Stamilio DM, Macones GA. Am J Obstet Gynecol. 2009 Nov; 201(5):466.e1-7. Epub 2009 Sep 26.

Report from the Second Cytomegalovirus and Immunosenescence Workshop. [Immun Ageing. 2011]
Report from the Second Cytomegalovirus and Immunosenescence Workshop.
Wills M, Akbar A, Beswick M, Bosch JA, Caruso C, Colonna-Romano G, Dutta A, Franceschi C, Fulop T, Gkrania-Klotsas E, et al. Immun Ageing. 2011 Oct 28; 8(1):10. Epub 2011 Oct 28.
Immune risk phenotype is associated with nosocomial lung infections in elderly in-patients. [Immun Ageing. 2011]
Immune risk phenotype is associated with nosocomial lung infections in elderly in-patients.
Plonquet A, Bastuji-Garin S, Tahmasebi F, Brisacier C, Ledudal K, Farcet J, Paillaud E. Immun Ageing. 2011 Oct 1; 8:8. Epub 2011 Oct 1.
Cytomegalovirus: pathogen, paradigm, and puzzle. [J Clin Invest. 2011]
Cytomegalovirus: pathogen, paradigm, and puzzle.
Boeckh M, Geballe AP. J Clin Invest. 2011 May 2; 121(5):1673-80.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Immunosenescence and Cytomegalovirus: where do we stand after a decade?
Immunosenescence and Cytomegalovirus: where do we stand after a decade?
Immun Ageing. 2010 Sep 7 ;7:13.

PubMed
Transcriptomic biomarkers of the response of hospitalized geriatric patients wit...
Transcriptomic biomarkers of the response of hospitalized geriatric patients with infectious diseases.
Immun Ageing. 2010 Aug 17 ;7:9.

PubMed
Effector T-cell induction and T-cell memory versus peripheral deletion of T cell...
Effector T-cell induction and T-cell memory versus peripheral deletion of T cells.
Immunol Rev. 1993 Jun ;133:199-223.

PubMed
Related Citations for PubMed (Select 20403167) (130)
PubMed
Related Citations for PubMed (Select 20673329) (107)
PubMed

Your browsing activity is empty.

Activity recording is turned off.